Significance of neutrophil to lymphocyte ratio as a predictor of outcome in head and neck cancer treated with definitive chemoradiation

被引:5
|
作者
Kazmierska, Joanna [1 ,2 ,4 ]
Bajon, Tomasz [1 ]
Winiecki, Tomasz [1 ]
Borowczak, Dominika [1 ]
Bandurska-Luque, Anna [1 ]
Jankowska, Malgorzata [1 ]
Zmijewska-Tomczak, Malgorzata [3 ]
机构
[1] Greater Poland Canc Ctr, Radiotherapy Dept 2, Poznan, Poland
[2] Univ Med Sci, Electroradiol Dept, Poznan, Poland
[3] Greater Poland Canc Ctr, Radiotherapy Dept 1, Poznan, Poland
[4] Greater Poland Canc Ctr, Radiotherapy & Oncol, Garbary 15, PL-61866 Poznan, Poland
关键词
neutrophil-to-lymphocyte ratio; head and neck cancer; prediction; MICROENVIRONMENT; CHEMOTHERAPY; RADIOTHERAPY; MECHANISMS; SURVIVAL; NLR;
D O I
10.5603/RPOR.a2023.0042
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background:The role of host immune system in carcinogenesis and response to treatment is increasingly studied, including predictive potential of circulating neutrophils and lymphocytes. The objective of the study was to evaluate the prognostic val-ue of pre-and post-treatment neutrophil-to-lymphocyte (NLR) for treatment outcome in patients diagnosed with squamous cell carcinoma of head and neck (HNSCC) treated with definitive chemoradiation. Materials and methods: Electronic medical records of patients were evaluated and NLR was calculated. Cox regression was used to assess the impact of selected variables on overall survival (OS), disease specific survival (DSS), progression free sur-vival (PFS) and distant failure free survival (DFFS). Logistic regression was used to estimate odds ratios of complete response with NLR. Results: 317 patients' records were included in the study. Increases in both pre-and post-NLR were associated with decreased OS in univariable analysis [hazard ratio (HR): 2.26 (1.25-4.07), p = 0.0068 and HR: 1.57 (1.03-2.37), p = 0.035 respectively). Post-NLR remained significant for OS in multivariable analysis [HR: 1.93 (1.22-3.1), p = 0.005] as well as for unfavorable DSS [HR: 2.31 (1.22-4.4), p = 0.01]. Pre-treatment NLR and nodal status correlated with shorter DFFS in multivariable analysis [HR 4.1 (1.14-14), p = 0.03 and HR 5.3: (1.62-18), p = 0.0062, respectively]. Strong correlation of increased both pre-and post-NLR with probability of clinical tumor response (CR) was found [odds ratio (OR): 0.23 (0.08-0.6), p = 0.003, and OR: 0.39 (0.2-0.8), p = 0.01 respectively]. Conclusion: NLR evaluated before and post treatment was a strong predictor of unfavorable treatment outcome and can be used for risk evaluation and clinical decision about treatment and post-treatment surveillance.
引用
收藏
页码:389 / 398
页数:10
相关论文
共 50 条
  • [1] The Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Head and Neck Cancer Patients Treated with Radiotherapy
    Cho, Yeona
    Kim, Jun Won
    Yoon, Hong In
    Lee, Chang Geol
    Keum, Ki Chang
    Lee, Ik Jae
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (12)
  • [2] Changes in Neutrophil-to-Lymphocyte Ratio (NLR) During Chemoradiation for Head and Neck Cancer Are Significant Predictor for Overall Survival
    Hyder, J.
    Molitoris, J.
    Engelman, A.
    Hanlon, A.
    D'Emic, N.
    Suntharalingam, M.
    Chuong, M. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S174 - S174
  • [3] Neutrophil-to-lymphocyte ratio as a predictor of surgical outcomes in head and neck cancer
    Kao, Derek D.
    Ferrandino, Rocco M.
    Roof, Scott A.
    Marshall, Deborah C.
    Khan, Mohemmed Nazir
    Chai, Raymond L.
    Park, Yeun-Hee A.
    Sigel, Keith M.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2023, 45 (08): : 1903 - 1912
  • [4] Neutrophil-to-Lymphocyte Ratio Predicts Survival in Head and Neck SCC Treated with Definitive Chemoradiotherapy
    Chandrasekara, S.
    Davis, S.
    Thomson, P.
    Haydon, A.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 56 - 56
  • [5] Overall Neutrophil-to-Lymphocyte Ratio and SUVmax of Nodal Metastases Predict Outcome in Head and Neck Cancer Before Chemoradiation
    Werner, Jonas
    Strobel, Klaus
    Lehnick, Dirk
    Rajan, Gunesh P.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Blood neutrophil to lymphocyte ratio as a predictor of response to chemotherapy in head and neck cancer.
    Novin, Kambiz
    Bahremani, Mohammad Hashemi
    Mortazavi, Nafiseh
    Ahmad, Ameri
    Razaghi, Zahra
    Fadavi, Pedram
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Neutrophil-to-lymphocyte ratio in head and neck cancer
    Haddad, Carol R.
    Guo, Linxin
    Clarke, Stephen
    Guminski, Alex
    Back, Michael
    Eade, Thomas
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2015, 59 (04) : 514 - 519
  • [8] Association of pretreatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation.
    Yu, Brian
    Ma, Sung Jun
    Khan, Michael
    Gill, Jasmin
    Iovoli, Austin
    Farrugia, Mark
    Wooten, Kimberly
    Gupta, Vishal
    McSpadden, Ryan
    Kuriakose, Moni A.
    Markiewicz, Michael R.
    Al-Afif, Ayham
    Hicks, Wesley L.
    Seshadri, Mukund
    Singh, Anurag K.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Neutrophil to lymphocyte ratio and outcome in stage III non-small cell lung cancer treated with definitive chemoradiation therapy.
    Murthy, Hemant S.
    Walker, Paul R.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation
    Brian Yu
    Sung Jun Ma
    Michael Khan
    Jasmin Gill
    Austin Iovoli
    Fatemeh Fekrmandi
    Mark K. Farrugia
    Kimberly Wooten
    Vishal Gupta
    Ryan McSpadden
    Moni A. Kuriakose
    Michael R. Markiewicz
    Ayham Al-Afif
    Wesley L. Hicks
    Mukund Seshadri
    Andrew D. Ray
    Elizabeth A. Repasky
    Anurag K. Singh
    BMC Cancer, 23